Asset Advisors Investment Management, LLC Eli Lilly & CO Transaction History

Asset Advisors Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $491,111 - $591,048	-3,600 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $99,711 - $116,388	-900 Reduced 20.0%	3,600 $399,000
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $166,965 - $196,530	-1,500 Reduced 25.0%	4,500 $584,000
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $476,550 - $533,880	-4,500 Reduced 42.86%	6,000 $694,000
Q3 2018 Oct 26, 2018	BUY	$85.86 - $107.31 $901,530 - $1.13 Million	10,500 New	10,500 $1.13 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.